Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Faiyaz Md. Efaz"'
Autor:
Md. Jaish Uddin, Hasina Akhter, Urmi Chowdhury, Jannatul Mawah, Sanzida Tul Karim, Mohammad Jomel, Md. Sirajul Islam, Mohammad Raqibul Islam, Latifa Afrin Bhuiyan Onin, Md. Ackas Ali, Faiyaz Md. Efaz, Mohammad A. Halim
Publikováno v:
Journal of Computational Chemistry. 44:887-901
The COVID-19 pandemic has been a public health emergency, with deadly forms constantly emerging around the world, highlighting the dire need for highly effective antiviral therapeutics. Peptide therapeutics show significant potential for this viral d
Autor:
Rosy Sultana, Joydip Biswas, Md. Giash Uddin, Faiyaz Md. Efaz, Md Ackas Ali, Mohabbat Hossain, Md. Tarikul Islam, Hossain Uddin Shekhar, Md. Walid Hossain, Muhammad Manjurul Karim, Abu A. Sajib, Mohammad A. Halim, Kaiissar Mannoor
Publikováno v:
Gene Reports. 31:101779
Autor:
Md Jaish Uddin, Akhter, Hasina, Chowdhury, Urmi, Jannatul Mawah, Sanzida Tul Karim, Jomel, Mohammad, Md Sirajul Islam, Islam, Mohammad Raqibul, Afrin, Latifa, Faiyaz Md Efaz, Md Ackas Ali, Halim, Mohammad A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe482bd4410e384195230b6f646c1eda
Autor:
Ackas Ali, Mohammad A. Halim, Faiyaz Md Efaz, Farjana Akter, Sayeda Samina Ahmed, M. A. S. K. Khan, Giash Uddin, Abdulla Al Mamun, Nabila Tabassum Tasfia, Mossammad Umme Chand Sultana
Publikováno v:
Journal of Biomolecular Structure & Dynamics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
In viral binding and entry, the Spike(S) protein of SARS-CoV-2 uses transmembrane serine protease 2 (TMPRSS2) for priming to cleavage themselves. In this study, we have screened ‘drug-like’ 7476 ligands and found that over thirty ligands can effe
Autor:
Shafiqul Islam, Shaila Akter, Faiyaz Md Efaz, Shafi Ahmad Talukder, Abu Sufian, Rimon Parves, Ackas Ali, Mohammad A. Halim, Zakaria Tashrif, Jahirul Islam
Publikováno v:
Journal of computational chemistryREFERENCES. 42(32)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously evolving. Although several vaccines were approved, this pandemic is still a major threat to public life. Till date, no established therapies are available against SARS-CoV-2